Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06364683 |
Other study ID # |
AIBU-HSF-SDEMIR-04 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
May 13, 2024 |
Est. completion date |
May 13, 2025 |
Study information
Verified date |
April 2024 |
Source |
Abant Izzet Baysal University |
Contact |
Halil Ilker YENCILEK, Chief Physician |
Phone |
+90 374 253 46 26 |
Email |
bolueah1[@]saglik.gov.tr |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
This study aims to determine the factors affecting exercise adherence in patients with
coronary artery disease (CAD). For this purpose, the following measurement tools will be used
respectively: (1) "Patient Information Form" including sociodemographic characteristics of
the patients and medical information related to the disease, (2) the Exercise Adherence
Rating Scale (EARS), (3) Exercise Self-Efficacy Scale (ESE) and, (4) Turkish-Health Literacy
Survey Europe-Q12 (HLS-EU-19-12Q-TR). Statistical analyses will be carried out by descriptive
statistics (number, percentage, mean, standard deviation, etc.), correlation analysis and
regression analysis.
Description:
Coronary Artery Disease (CAD) is the most common form of cardiovascular disease in the world
and is one of the leading causes of mortality and morbidity in Turkey and worldwide. Exercise
training is very important in the treatment of CAD because of its various cardiovascular
benefits. However, most patients have been shown to have low to moderate adherence rates to
the recommended exercise prescription. The results of a limited number of studies show that
the factors affecting exercise adherence in patients with CAD need to be supported by new
studies. This study aims to determine the factors affecting exercise adherence in patients
with coronary artery disease (CAD). The study will be conducted with CAD patients followed up
in the cardiology clinics of a tertiary care hospital in northern Turkey. A cohen's d will be
calculated using preliminary data from 20 patients using Exercise Adherence Rating Scale
(EARS), and an adequate sample size will be determined with a 95% confidence interval, a bias
level of 0.05, and 80% power. Patients with a diagnosis of CAD confirmed by a physician at
least one year ago, who have been recommended any exercise/physical activity by a physician
according to article 1 of EARS, who are ≥18 years old and <75 years old, and who have the
ability to understand and speak Turkish will be included in the study. The data will be
collected using the following measurement tools respectively: (1) "Patient Information Form"
including sociodemographic characteristics of the patients and medical information related to
the disease, (2) the Exercise Adherence Rating Scale (EARS), (3) Exercise Self-Efficacy Scale
(ESE) and, (4) Turkish-Health Literacy Survey Europe-Q12 (HLS-EU-19-12Q-TR). Statistical
analyses will be carried out by descriptive statistics (number, percentage, mean, standard
deviation, etc.), correlation analysis and regression analysis.